Julia Aijun Wang - 30 Jun 2021 Form 3 Insider Report for BeiGene, Ltd. (ONC)

Role
Chief Financial Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
ONC
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
3
Filing time
01 Jul 2021, 16:55:32 UTC
Next filing
01 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BGNE Ordinary Shares 83,876 30 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BGNE Share Option (Right to Buy) 30 Jun 2021 Ordinary Shares 104,754 $14.66 Direct F2
holding BGNE Share Option (Right to Buy) 30 Jun 2021 Ordinary Shares 177,853 $26.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying unvested restricted share units.
F2 These securities vest over a four-year period as follows: 25% on June 30, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
F3 These securities vest over a four-year period as follows: 25% on June 16, 2022 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney